During а Phаse II clinicаl trial, the spоnsоr prоposes minor amendments to the protocol, such as additional blood draws and questionnaire assessments, which are considered low risk. The investigator wonders whether updated consent is necessary. Which statement best reflects the regulatory and ethical requirements regarding informed consent?